Echocardiographic measurements have a sensitivity of 83% and specificity of 72% in detecting PAH so patients with an elevated PASP should then go on to have an RHC to confirm the presence of PAH [141]. This evidence concerns the gene CPB1 and pulmonary arterial hypertension.